Schizophrenia as segmental progeria

por Papanastasiou, Evangelos, Gaughran, Fiona, Smith, Shubulade
Publicado 2011

Physical Health Problems in Psychosis: Is It Time to Consider the Views of Family Carers?

por Onwumere, Juliana, Shiers, David, Gaughran, Fiona
Publicado en Front Psychiatry (2018)

Evaluation of a Physical health plan for people with psychosis: a protocol for a quality improvement study

por Williams, Julie, Sevdalis, Nick, Gaughran, Fiona
Publicado en Pilot Feasibility Stud (2019)

T147. CAN HIGH INTENSITY INTERVAL TRAINING (HIIT) IMPROVE PHYSICAL AND MENTAL HEALTH OUTCOMES? A META-REVIEW OF THE GLOBAL BENEFITS OF HIIT AND FOCUSED SYSTEMATIC REVIEW OF THE EFF...

por Martland, Rebecca, Stubbs, Brendon, Gaughran, Fiona
Publicado en Schizophr Bull (2020)

Vitamin D in the time of the coronavirus (COVID-19) pandemic – a clinical review from a public health and public mental health perspective

por Werneke, Ursula, Gaughran, Fiona, Taylor, David M.
Publicado en Ther Adv Psychopharmacol (2021)

Melperone in Treatment-Refractory Schizophrenia: A Case Series

por Whiskey, Eromona, Vavrova, Marta, Gaughran, Fiona, Taylor, David
Publicado 2011

‘Walk This Way’ – a pilot of a health coaching intervention to reduce sedentary behaviour and increase low intensity exercise in people with serious mental illness: study protocol...

por Williams, Julie, Stubbs, Brendon, Gaughran, Fiona, Craig, Tom
Publicado en Trials (2016)

M189. A PILOT RANDOMISED CONTROLLED TRIAL TO ASSESS THE FEASIBILITY AND ACCEPTABILITY OF HIGH INTENSITY INTERVAL TRAINING (HIIT) AMONG INPATIENTS WITH SEVERE MENTAL ILLNESS (SMI)

por Martland, Rebecca, Stubbs, Brendon, Gaughran, Fiona, Onwumere, Juliana
Publicado en Schizophr Bull (2020)

Clozapine and COVID-19

por Silva, Edward, Gee, Siobhan, Smith, Shubulade, Gaughran, Fiona
Publicado en BJPsych Bull (2020)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics

por Lally, John, Gaughran, Fiona, Timms, Philip, Curran, Sarah R
Publicado en Pharmgenomics Pers Med (2016)

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism

por Kočovská, Eva, Gaughran, Fiona, Krivoy, Amir, Meier, Ute-Christiane
Publicado en Front Psychiatry (2017)

Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed t...

por Majer, Istvan M., Gaughran, Fiona, Sapin, Christophe, Beillat, Maud, Treur, Maarten
Publicado en J Mark Access Health Policy (2015)

Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust

por Douglas-Hall, Petrina, Dzahini, Olubanke, Gaughran, Fiona, Bile, Ahmed, Taylor, David
Publicado en Ther Adv Psychopharmacol (2016)

Place of death and other factors associated with unnatural mortality in patients with serious mental disorders: population-based retrospective cohort study

por Wilson, Rebecca, Gaughran, Fiona, Whitburn, Tara, Higginson, Irene J., Gao, Wei
Publicado en BJPsych Open (2019)

Effects of Transcranial Direct Current Stimulation (tDCS) and Approach Bias Modification (ABM) training on food cravings in people taking antipsychotic medication

por Grycuk, Luiza, Gordon, Gemma, Gaughran, Fiona, Campbell, Iain C., Schmidt, Ulrike
Publicado en Trials (2020)

Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis

por Gomez, Lucia, Stubbs, Brendon, Shirazi, Ayala, Vancampfort, Davy, Gaughran, Fiona, Lally, John
Publicado en Curr Osteoporos Rep (2016)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review

por Lally, John, Sahl, Abdullah Bin, Murphy, Kieran C., Gaughran, Fiona, Stubbs, Brendon
Publicado en Clin Psychopharmacol Neurosci (2019)

The effect of clozapine on factors controlling glucose homeostasis

por Howes, Oliver D, Gaughran, Fiona P, Amiel, Stephanie, Murray, Robin M, Pilowsky, Lyn S
Publicado 2004

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?

por Iyegbe, Conrad, Allen, Lauren, Lally, John, DiForti, Marta, Murray, Robin, Gaughran, Fiona
Publicado en Schizophr Bull (2018)

Management of clozapine treatment during the COVID-19 pandemic

por Gee, Siobhan, Gaughran, Fiona, MacCabe, James, Shergill, Sukhi, Whiskey, Eromona, Taylor, David
Publicado en Ther Adv Psychopharmacol (2020)